NAVCO PHARMACEUTICALS INC (NAV.CA) Stock Income Statement
TSX-V:NAV - TSX Venture Exchange - CA63942R1091 - Common Stock - Currency: CAD
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | ||||
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 1.34M | 1.60M | 1.47M | |||
| Selling, General, and Administrative Expenses | 1.32M | 1.57M | 1.42M | |||
| Operating Income | -1.34M | -1.60M | -1.47M | |||
| Interest Income/Expense | -16.30K | -16.00K | -12.50K | |||
| Non Recurring Items | N/A | -105.90K | -667.10K | |||
| Income Before Taxes | -1.46M | -1.72M | -2.15M | |||
| Net Income | -1.46M | -1.72M | -2.15M | |||
| EBITDA | -1.28M | -1.53M | -1.42M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.07 | |||
| Statistics | ||||||
All data in CAD